クロセチンエステルの市場規模・シェア分析：用途 (機能性食品&飲料・医薬品) 別 - 世界の収益推計・需要予測 (～2030年)

世界のクロセチンエステルの市場規模は、2023年の41万1,300米ドルから、予測期間中はCAGR 6.5％で推移し、2030年には63万4,300米ドルの規模に成長すると予測されています。

この背景には、機能性食品や栄養補助食品における合成成分の代替品として、植物由来の天然成分への関心が高まっていることがあります。健康とウェルネスの動向の高まり、消費者の意識の高まり、規制の状況、栄養と医療におけるこれらの化学物質の使用も業界の拡大を後押ししています。クロセチンエステルの健康上の利点と実行可能な用途を探るための継続的な研究も業界の成長をさらに後押ししています。

人口の増加と食糧生産強化の要求も、この産業の成長を後押ししています。都市化が進んだ国では耕地が限られているため、現在の農地の生産性を高めることが不可欠になっています。クロセチンエステルは、栄養素の流出を抑えることによって、植物が栄養素を利用しやすいようにし、植物の発育を促進し、作物の収量を増加させます。

市場インサイト：

2023年の業界シェアは欧州が45%で最大でした。この地域の優位性は、昔からのサフランの受容にあります。クロセチンエステルの原料となるサフランは、イタリア、ギリシャ、スペインを中心に、この地域の各地でかなり古くから栽培されています。

アジア太平洋地域は、今後数年でもっとも速いCAGR 10％で成長すると予測されています。これは、同地域で機能性食品・飲料に対するニーズが高まっていることと、抗酸化物質に関連する医療上の利点が注目されつつあるためです。また、アジア太平洋諸国の顧客は健康に対する意識が高まっているため、天然素材だけでなく機能性食品素材も高い需要を示しています。

当レポートでは、世界のクロセチンエステルの市場を調査し、市場の定義と概要、市場影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の詳細分析、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 調査範囲

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場指標

第5章 業界の展望

• 市場力学
  • 動向
  • 促進要因
  • 抑制要因・課題
  • 促進要因・抑制要因の影響分析
• COVID-19の影響
• ポーターのファイブフォース分析

第6章 世界市場

• 概要
• 市場収益の推移・予測：用途別
• 市場収益の推移・予測：地域別

第7章 北米市場

第8章 欧州市場

第9章 アジア太平洋市場

第10章 ラテンアメリカ市場

第11章 中東・アフリカ市場

第12章 米国市場

第13章 カナダ市場

第14章 ドイツ市場

第15章 フランス市場

第16章 英国市場

第17章 イタリア市場

第18章 スペイン市場

第19章 日本市場

第20章 中国市場

第21章 インド市場

第22章 オーストラリア市場

第23章 韓国市場

第24章 ブラジル市場

第25章 メキシコ市場

第26章 サウジアラビア市場

第27章 南アフリカ市場

第28章 UAE市場

第29章 競合情勢

• 主要企業・製品のリスト
• 主要企業の競合ベンチマーキング
• 主要企業の製品ベンチマーク
• 最近の戦略的展開

第30章 企業プロファイル

• Chengdu Biopurify Phytochemicals Ltd.
• Chengdu Gelipu Biotechnology Co. Ltd.
• Tokyo Chemical Industry Co. Ltd
• Amadis Chemical Company Limited
• Hunan Jiahang Pharmaceutical Technology Co. Ltd.
• Cayman Chemical
• Biosynth
• Plamed Green Science Group
• Shaanxi UndersunBiomedtech Co. Ltd.
• Chongqing Kang Biotechnology Co. Ltd.
• Hainan Super Biotech Co. Ltd.
• Xi'an Sgonek Biological Technology Co. Ltd.
• Kingherbs Limited
• Xi'an Lyphar Biotech Co. Ltd.

第31章 付録

Key Highlights

The crocetin esters market was valued at USD 411.3 thousand in 2023, and it will increase to USD 634.3 thousand, advancing at a 6.5% compound annual growth rate, by 2030.

This is because of the increasing interest in plant-based and natural items as a replacement for synthetic ingredients in functional foods and dietary supplements.

The rising trends of health & wellness, growing consumer consciousness, the regulatory situation, and the usage of these chemicals in nutrition and medicine are also helping the industry expand.

The continuing studies to explore the health benefits and viable applications of crocetin esters are further assisting the growth of the industry.

These mixtures are being examined for their possible role in decreasing oxidative stress, supporting cognitive well-being, and controlling CVDs.

The rising populace and the requirement to enhance food production are also aiding the growth of this industry.

With limited arable land in well-urbanized nations, it has become vital to enhance the productivity of the present farmlands.

Crocetin esters assist in optimizing the accessibility of nutrients for plants by reducing their draining, thus enhancing plant development, which can result in greater crop yields.

Market Insights

Europe accounted for the largest share of the industry in 2023, with a 45% share.

The dominance of this region in the enduring understanding of saffron as well as its acceptance.

Saffron, from which crocetin esters are produced, has been farmed in various areas of this region for quite a long time, notably in Italy, Greece, and Spain.

APAC will advance at the fastest compound annual growth rate, of 10%, in the years to come.

This will be because of the region's rising need for functional foods & beverages and the growing concentration of the medical benefits linked to antioxidants.

Natural as well as functional food ingredients are in high demand because customers in APAC nations become more conscious of their well-being.

The functional food and beverage category accounted for the largest share of the industry in 2023, with a 60% share.

Crocetin esters are progressively being employed in confectionery, dairy, beverages, and convenience foods, because of their important part in protecting these products' stability.

They, similarly, assist in increasing the taste, aroma, and assortment of food & beverages.

Functional foods fulfill people's everyday nutrition requirements, as a result, customers are increasingly searching for them for their overall wellbeing.

Pharmaceuticals will advance at a rapid compound annual growth rate, of 8%, in the years to come.

Due to the robust anti-inflammatory, neuroprotective, and antioxidant features of crocetin esters, pharmaceutical firms have been progressively using them as APIs or various other ingredients in the formulations of drugs.

A growing count of clinical trials and studies are being performed on these bioactive substances to explore their possible therapeutic applications for cardiovascular illnesses, neurological disorders, and tumors.

In the crocetin esters industry, competition circles around the introduction of saffron-derived extracts and research on applications of these mixtures in cosmetics, functional foods, and pharmaceuticals.

The competition in this industry is rather tough, with the existence of several globally operating and localized participants.

Table of Contents

Chapter 1. Research Scope

• 1.1. Research Objectives
• 1.2. Market Definition
• 1.3. Analysis Period
• 1.4. Market Size Breakdown by Segments
  • 1.4.1. Market size breakdown, by application
  • 1.4.2. Market size breakdown, by region
  • 1.4.3. Market size breakdown, by country
• 1.5. Market Data Reporting Unit
  • 1.5.1. Value
• 1.6. Key Stakeholders

Chapter 2. Research Methodology

• 2.1. Secondary Research
  • 2.1.1. Paid
  • 2.1.2. Unpaid
  • 2.1.3. P&S Intelligence database
• 2.2. Primary Research
• 2.3. Market Size Estimation
• 2.4. Data Triangulation
• 2.5. Currency Conversion Rates
• 2.6. Assumptions for the Study
• 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

• 5.1. Market Dynamics
  • 5.1.1. Trends
  • 5.1.2. Drivers
  • 5.1.3. Restraints/challenges
  • 5.1.4. Impact analysis of drivers/restraints
• 5.2. Impact of COVID-19
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Bargaining power of buyers
  • 5.3.2. Bargaining power of suppliers
  • 5.3.3. Threat of new entrants
  • 5.3.4. Intensity of rivalry
  • 5.3.5. Threat of substitutes

Chapter 6. Global Market

• 6.1. Overview
• 6.2. Market Revenue, by Application (2017-2030)
• 6.3. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

• 7.1. Overview
• 7.2. Market Revenue, by Application (2017-2030)
• 7.3. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

• 8.1. Overview
• 8.2. Market Revenue, by Application (2017-2030)
• 8.3. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

• 9.1. Overview
• 9.2. Market Revenue, by Application (2017-2030)
• 9.3. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

• 10.1. Overview
• 10.2. Market Revenue, by Application (2017-2030)
• 10.3. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

• 11.1. Overview
• 11.2. Market Revenue, by Application (2017-2030)
• 11.3. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

• 12.1. Overview
• 12.2. Market Revenue, by Application (2017-2030)
• 12.3. Market Revenue, by Industry (2017-2030)

Chapter 13. Canada Market

• 13.1. Overview
• 13.2. Market Revenue, by Application (2017-2030)
• 13.3. Market Revenue, by Industry (2017-2030)

Chapter 14. Germany Market

• 14.1. Overview
• 14.2. Market Revenue, by Application (2017-2030)
• 14.3. Market Revenue, by Industry (2017-2030)

Chapter 15. France Market

• 15.1. Overview
• 15.2. Market Revenue, by Application (2017-2030)
• 15.3. Market Revenue, by Industry (2017-2030)

Chapter 16. U.K. Market

• 16.1. Overview
• 16.2. Market Revenue, by Application (2017-2030)

Chapter 17. Italy Market

• 17.1. Overview
• 17.2. Market Revenue, by Application (2017-2030)

Chapter 18. Spain Market

• 18.1. Overview
• 18.2. Market Revenue, by Application (2017-2030)

Chapter 19. Japan Market

• 19.1. Overview
• 19.2. Market Revenue, by Application (2017-2030)

Chapter 20. China Market

• 20.1. Overview
• 20.2. Market Revenue, by Application (2017-2030)

Chapter 21. India Market

• 21.1. Overview
• 21.2. Market Revenue, by Application (2017-2030)

Chapter 22. Australia Market

• 22.1. Overview
• 22.2. Market Revenue, by Application (2017-2030)

Chapter 23. South Korea Market

• 23.1. Overview
• 23.2. Market Revenue, by Application (2017-2030)

Chapter 24. Brazil Market

• 24.1. Overview
• 24.2. Market Revenue, by Application (2017-2030)

Chapter 25. Mexico Market

• 25.1. Overview
• 25.2. Market Revenue, by Application (2017-2030)

Chapter 26. Saudi Arabia Market

• 26.1. Overview
• 26.2. Market Revenue, by Application (2017-2030)

Chapter 27. South Africa Market

• 27.1. Overview
• 27.2. Market Revenue, by Application (2017-2030)

Chapter 28. U.A.E. Market

• 28.1. Overview
• 28.2. Market Revenue, by Application (2017-2030)

Chapter 29. Competitive Landscape

• 29.1. List of Market Players and their Offerings
• 29.2. Competitive Benchmarking of Key Players
• 29.3. Product Benchmarking of Key Players
• 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

• 30.1. Chengdu Biopurify Phytochemicals Ltd.
  • 30.1.1. Business overview
  • 30.1.2. Product and service offerings
  • 30.1.3. Key financial summary
• 30.2. Chengdu Gelipu Biotechnology Co. Ltd.
  • 30.2.1. Business overview
  • 30.2.2. Product and service offerings
  • 30.2.3. Key financial summary
• 30.3. Tokyo Chemical Industry Co. Ltd
  • 30.3.1. Business overview
  • 30.3.2. Product and service offerings
  • 30.3.3. Key financial summary
• 30.4. Amadis Chemical Company Limited
  • 30.4.1. Business overview
  • 30.4.2. Product and service offerings
  • 30.4.3. Key financial summary
• 30.5. Hunan Jiahang Pharmaceutical Technology Co. Ltd.
  • 30.5.1. Business overview
  • 30.5.2. Product and service offerings
  • 30.5.3. Key financial summary
• 30.6. Cayman Chemical
  • 30.6.1. Business overview
  • 30.6.2. Product and service offerings
  • 30.6.3. Key financial summary
• 30.7. Biosynth
  • 30.7.1. Business overview
  • 30.7.2. Product and service offerings
  • 30.7.3. Key financial summary
• 30.8. Plamed Green Science Group
  • 30.8.1. Business overview
  • 30.8.2. Product and service offerings
  • 30.8.3. Key financial summary
• 30.9. Shaanxi UndersunBiomedtech Co. Ltd.
  • 30.9.1. Business overview
  • 30.9.2. Product and service offerings
  • 30.9.3. Key financial summary
• 30.10. Chongqing Kang Biotechnology Co. Ltd.
  • 30.10.1. Business overview
  • 30.10.2. Product and service offerings
  • 30.10.3. Key financial summary
• 30.11. Hainan Super Biotech Co. Ltd.
  • 30.11.1. Business overview
  • 30.11.2. Product and service offerings
  • 30.11.3. Key financial summary
• 30.12. Xi'an Sgonek Biological Technology Co. Ltd.
  • 30.12.1. Business overview
  • 30.12.2. Product and service offerings
  • 30.12.3. Key financial summary
• 30.13. Kingherbs Limited
  • 30.13.1. Business overview
  • 30.13.2. Product and service offerings
  • 30.13.3. Key financial summary
• 30.14. Xi'an Lyphar Biotech Co. Ltd.
  • 30.14.1. Business overview
  • 30.14.2. Product and service offerings
  • 30.14.3. Key financial summary

Chapter 31. Appendix

• 31.1. Abbreviations
• 31.2. Sources and References
• 31.3. Related Reports